Results
1 -
10 of
27Robert F. Anderson, Sujata S. Shinde, Andrej Maroz, Maruta Boyd, Brian D. Palmer and William A. Denny.
Intermediates in the reduction of the antituberculosis drug PA-824, (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine, in aqueous solution, Org. Biomol. Chem., 2008, 6, 1973. Rather Muzafar Ahmad, Lone Ali Mohd, Teli Bisma, Bhat Zubair Shanib, Singh Paramjeet, Maqbool Mubashir, Shairgojray Bashir Ahmad, Dar Mohd Jamal, Amin Shajrul, Yousuf Syed Khalid, Bhat Bilal A., Ahmad Zahoor.
The synthesis, biological evaluation and structure–activity relationship of 2-phenylaminomethylene-cyclohexane-1,3-diones as specific anti-tuberculosis agents, MedChemComm, 2017 Neue Medikamente zur Behandlung der Tuberkulose, Der Internist Mechanisms of Action and Resistance of the Antimycobacterial Agents, Antimicrobial Drug Resistance New Antituberculous Drugs in Development, Current HIV/AIDS Reports Neue Ans??tze in der Therapie der Tuberkulose, Der Pneumologe Emerging Therapies, Handbook of Tuberculosis Drug Resistant and Persistent Tuberculosis: Mechanisms and Drug Development, Antibiotic Discovery and Development